OBESTATIN (RAT) | CAS:869705-22-6

We serve OBESTATIN (RAT) CAS:869705-22-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
OBESTATIN (RAT)

Chemical Name:OBESTATIN (RAT)
CAS.NO:869705-22-6
Synonyms:OBESTATIN (RAT)
 
Physical and Chemical Properties:
Molecular Formula C114H174N34O31
Molecular Weight 2516.81000
 
Specification:
Appearance:White to off-white powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Endogenous peptide derived from the same prepropeptide as ghrelin. Reported to suppress food intake and reduce body weight-gain in rats.



Contact us for information like OBESTATIN (RAT) chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,OBESTATIN (RAT) physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,OBESTATIN (RAT) Use and application,OBESTATIN (RAT) technical grade,usp/ep/jp grade.


Related News: The API is not made by only one reaction from the raw materials but rather it becomes an API via several chemical compounds.Propyl isocyanate manufacturer Chinese nationals coming from China and connecting through another foreign airport will be denied travel. Those with pre-clearance are exempted.N1-Methyl-4-nitrobenzene-1,2-diamine supplier There are a number of common signs that you may be infected, most of which are respiratory such as experiencing breathing difficulties, shortness of breath and having a cough.1-Hydroxyethylethoxypiperazine vendor The oral form of rigosertib was developed to provide a potentially more convenient dosage form for use where the duration of treatment may extend to multiple years.From a global perspective, China’s API companies have also performed well. According to the report of the American Transparent Medicine website, in 2016 the top ten pharmaceutical companies in the global API market, Chinese pharmaceutical companies accounted for 6 seats.